NASDAQ:AVTX | Net Income | Avalo Therapeutics, Inc.

Complete source-backed net income history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$36.36M
2026-03-31-$19.63M
2025-12-31-$13.72M
2025-09-30-$30.63M
2025-06-30-$20.77M
2025-03-31-$13.15M
2024-12-31-$35.34M
2024-09-30$23.04M
2024-06-30$98.46M
2024-03-31-$121.29M
2023-12-31-$8.17M
2023-09-30-$5.23M
2023-06-30-$8.19M
2023-03-31-$9.96M
2022-12-31-$9.81M
2022-09-30$3.19M
2022-06-30-$12.99M
2022-03-31-$22.05M
2021-12-31-$19.2M
2021-09-30-$17.4M
2021-06-30-$17.11M
2021-03-31-$30.68M
2020-12-31-$15.64M
2020-09-30-$13.46M
2020-06-30-$13.28M
2020-03-31-$21.12M
2019-12-31$1.62M
2019-09-30-$4.02M
2019-06-30-$6.22M
2019-03-31-$7.45M
2018-12-31-$5.56M
2018-09-30-$24.6M
2018-06-30-$6.01M
2018-03-31-$3.88M
2017-12-31-$3.09M
2017-09-30$18.72M
2017-06-30-$1.8M
2017-03-31-$1.96M
2016-12-31-$1.64M
2016-09-30-$6.17M
2016-06-30-$3.52M
2016-03-31-$5.14M
2015-12-31-$3.65M
2015-09-30-$691,081.00
2015-06-30-$2.91M
2015-03-31-$3.24M
2014-12-31-$2.52M
2014-09-30-$5.84M

Annual Net Income

DateNet Income
2025-12-31-$78.26M
2024-12-31-$35.13M
2023-12-31-$31.54M
2022-12-31-$41.66M
2021-12-31-$84.38M
2020-12-31-$63.5M
2019-12-31-$16.07M
2018-12-31-$40.05M
2017-12-31$11.87M
2016-12-31-$16.47M
2015-12-31-$10.49M
2014-12-31-$16.06M
2013-12-31-$13.05M